Overall, our results demonstrated the ability of SPRY4-IT1, which was found to be upregulated in advanced colorectal, breast, and ovarian cancer tumor types, to promote cancer cell migration/invasion and metastasis, consistent with the previous report. Here, SPRY4 is linked to cancer.